Bellmunt, Joaquim ;
de Wit, Ronald ;
Fradet, Yves...
Bellmunt , J , de Wit , R , Fradet , Y , Climent , M A , Petrylak , D P , Lee , J-L , Fong , L , Necchi , A , Sternberg , C N , O'Donnell , P H , Powles , T , Plimack , E R , Bajorin , D F , Balar , A V , Castellano , D , Choueiri , T K , Culine , S , Gerritsen , W , Gurney , H , Quinn , D I , Vuky , J , Vogelzang , N J , Cristescu , R , Lunceford , J , Saadatpour , A , Loboda , A , Ma , J , Rajasagi , M , Godwin , J L , Moreno , B H & Grivas , P 2022 , ' Putative biomarkers of clinical benefit with pembrolizumab in advanced urothelial cancer : results from the KEYNOTE-045 and KEYNOTE-052 landmark trials ' , Clinical Cancer Research , vol. 28 , no. 10 , pp. 2050-2060 . https://doi.org/10.1158/1078-0432.CCR-21-3089.
,
2022
